News

Introducing In Practice: Your New Go-To for All Things Community Oncology

Dr. Kashyap Patel May 29, 2026

Meet In Practice, a new community oncology hub with expert insights, news, videos, and practical tools designed to support teams, strengthen care, and keep practices connected.

ASCO 2026

Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC

June 1, 2026

ASCO 2026

Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC

June 1, 2026

ASCO 2026

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

Our Insights

Articles, expert reviews, and opinion pieces from our leaders out in the field and treating populations

In Your Practice

HER2 Heartbreak: Managing Trastuzumab Cardiotoxicity in Breast Cancer

Dr. Courtney Muche; Dr. Matthew Mattila April 16, 2026

In Your Practice

Virtual Collaborative Care

A virtual collaborative care model helped breast cancer patients reduce depression and anxiety while improving quality of life, appointment attendance, and medication adherence—without adding burden to oncology teams.

Dr. Nina Balanchivadze; Dr. Kyle Lavin May 29, 2026

Patient Populations

Rural Cancer Mortality Rising: ACS Study Shows Widening Disparities

April 16, 2026

Patient Populations

Empowering Decision-Making in Older Adults With Cancer

May 29, 2026

In Your Practice

Drug Shortages — There Are Drivers We Can Address

Dawn Holcombe April 16, 2026

Beyond the Needle: Liquid Biopsy & the Precision Revolution in Cancer

IN MY OPINION

Beyond the Needle: Liquid Biopsy & the Precision Revolution in Cancer

Watch Now

Agarwala

Part 4: Dr. Sanjiv Agarwala on Work-Work Balance in Community Oncology

Dr. Sanjiv Agarwala April 15, 2026

Part 3: Dr. Sanjiv Agarwala on Cutting Through Oncology Info Overload

Dr. Sanjiv Agarwala April 6, 2026

Part 2: Dr. Sanjiv Agarwala on How Community Oncologists Stay Informed (and In Practice)

Dr. Sanjiv Agarwala March 25, 2026

Listen Now

Cancer, Clearly — our flagship podcast

Delving Beyond the Infusion With Dr. Jennifer Brown and the AMPLIFY Trial’s Oral Breakthrough for CLL

In this episode, we sit down with Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, to unpack the AMPLIFY trial that is reshaping chronic lymphocytic leukemia (CLL) treatment. She explains how this new oral combination isn’t just effective but patient-friendly, cutting down on complexity and paving the way for more accessible care. Tune in to hear how this breakthrough is setting the stage for the future of CLL therapy.

Latest News

ASCO 2026

Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC

June 1, 2026

ASCO 2026

Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC

June 1, 2026

ASCO 2026

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

Explore by Topic

Cancer Types

In-depth coverage of specific malignancies, from common to rare cancers.

Therapeutic Approaches

Immunotherapy, targeted therapy, chemotherapy, and emerging treatment modalities.

Side Effect Management

Explore oncology content organized by side effect management. Find the latest research, treatment updates, and…

Diagnostics + Biomarkers

Explore oncology content organized by diagnostics + biomarkers. Find the latest research, treatment updates, and…